Toul Meditech preventing post-operative and surgical site infections

Every infection creates unnecessary suffering for the patient and significant cost for the hospital Every infection cost around 20.700,00 $ Pennsylvania hospital (USA Cecil Connolly Washington Post, July 13, 2005) One MRSA Infection cost $27,082, one MSSA Infection $9,661 (Dr. Murray Abramson, 9/28/1997 TORONTO, Ont. - Duke University Medical Center) Every Infection cost approx. $22,000 South Australia (Dr Collignon, an infectious diseases specialist and microbiologist at Canberra Hospital April 9, 2005) An Infection during a Hip-replacement can lead to permanent invalidity and even lead to amputation of the limb. The costs for the hospital/company ranges from €75.000,-- €150.000.

2 / Toul Title or job number / 7/10/2007

Numbers of Methicillin-resistent Staphylococcus aureus 2002 in Europe

3 / Toul Title or job number / 7/10/2007

Toul Meditech technology is a cost efficient solution with quick return on investment • “Money-saver” for hospitals, insurance companies and for the society. Saving patients from unnecessary suffering caused by infections, re-operation, loss of income etc. Shorter hospital stay, no re-operations, less use of antibiotics etc. • Money earner for Private hospitals, Insurance companies. Increased number of operations due to a faster flow of patients. • Toul Meditech technology has no installation cost for additional air and low running costs, is instantly ready to use and easy to handle. • All together the payback time is very short – avoid one infection and it is paid for.

4 / Toul Title or job number / 7/10/2007

Toul Meditech technology Solving the problem – improved surgical environments and better routines

• Toul Meditech AB provides Ultraclean Laminar Air Flow. • A HEPA filter separates the bacteria carrying particles from the OR air to 99,97 %. The air is then passed through a sterilized LAF screen(dosposable) that provides a piston of air.

• The TOUL unit can be placed extremely close to the surgical area (the wound). The Ultraclean Laminar Air Flow transports the contaminated particles away from the wound area. • Toul Meditech technology is proven to be very efficient. studies show results of less than 1 CFU/m air.

5 / Toul Title or job number / 7/10/2007

Toul Meditech portfolio

TOUL 200 – Ceiling Mounted Unit

TOUL 400 – Mobile Unit

6 / Toul Title or job number / 7/10/2007

TOUL 300 – Instrument Table

And it works… Results

Samariterhemmet, Uppsala University Hospital, Sweden

8 / Toul Title or job number / 7/10/2007

Statistics from Samariterhemmet, part of Uppsala University Hospital during 8 years of cruciate ligament construction operations

9 / Toul Title or job number / 7/10/2007

Samariterhemmet, Uppsala University Hospital, Sweden

”We have successfully used the TOUL units and our infection rate after cruciate ligament operation has dropped to less than 1%” Göran Angergård, Chairman, Dept of Day Surgery, Uppsala University Hospital, Sweden

10 / Toul Title or job number / 7/10/2007

3

Colony Forming Units (CFU/m air)

0 CFU in wound area – No infection risk

9 CFU in wound area – High infection risk

1 CFU in wound area – low infection risk

30 CFU in wound area – Unacceptable

11 / Toul Title or job number / 7/10/2007

Contamination level in the operating room

CFU’s on the instrument table

12 / Toul Title or job number / 7/10/2007

Västerås Hospital Orthopedic Dept. Full Back Surgery

13 / Toul Title or job number / 7/10/2007

Västerås Hospital Orthopedic Dept. Full Back Surgery CFU test Back Operation

Dag 1: test 3 och 4 without TOUL 400 Dag 2: test 4 without TOUL 400

14 / Toul Title or job number / 7/10/2007

Södersjukhuset, Sweden

15 / Toul Title or job number / 7/10/2007

CFU/measurements at Södersjukhuset hospital

16 / Toul Title or job number / 7/10/2007

Test results

17 / Toul Title or job number / 7/10/2007

Test results

18 / Toul Title or job number / 7/10/2007

Karolinska sjukhuset, Sweden

19 / Toul Title or job number / 7/10/2007

Measurements from Karolinska universitetssjukhuset, Sweden

20 / Toul Title or job number / 7/10/2007

Hip tumour

21 / Toul Title or job number / 7/10/2007

Measurements from Karolinska universitetssjukhuset, Sweden

22 / Toul Title or job number / 7/10/2007

Measurements from Karolinska universitetssjukhuset, Sweden

23 / Toul Title or job number / 7/10/2007

Motala Hospital, Sweden

24 / Toul Title or job number / 7/10/2007

Motala Hospital, Sweden • Primary partial hip prosthesis with cement • Primary total hip without cement • Primary total hip with hybrid technology • Primary total hip without cement • Primary partial knee with cement • Primary total knee with cement • Total: 295 operations with Toul Meditech systems • So far, No reported infections

25 / Toul Title or job number / 7/10/2007

Telge Ortopedi, Södertälje Sweden

26 / Toul Title or job number / 7/10/2007

920 knee operations with Toul Meditech No reported infections, so far

27 / Toul Title or job number / 7/10/2007

Toul Meditech - applications Solving the problem – improved surgical environments and better routines

• • • • • •

Day-Hospital General surgery Day surgery increase of O.R for minor surgery Emergency departments Burn injured patients Implantation surgery Patients who are undergoing chemotherapy • High risk patients • Field hospitals • Keeping sterile conditions for instruments during surgery

28 / Toul Title or job number / 7/10/2007

Toul Meditech technology in summary Solving the problem – improved surgical environments and better routines

• Reduction of the contamination in surgical site • Quick and easy solution for producing ultra clean air • Increase of day surgery due to the use of minor rooms for interventions • Ultra clean air in wound area • Easy to move • Lower investment cost • Easy to use • Easy to clean

29 / Toul Title or job number / 7/10/2007